Tag Archives: pharmaceutical industry
Is Free, Canada-Wide Access to HIV Medications Reasonable?
Julian Hopwood-Raja argues that universal, barrier-free access to HIV medicines is not just a matter of beneficence for patients and the health system but important for public health and ethical resource allocation.
Whose Responsibility Are Ethical Issues in Phase 1 Research?
Dessislava Fessenko reveals that ethical concerns surrounding the participation of healthy volunteers in Phase 1 clinical trials have deep roots in broader social conditions, which require social policy responses.
Access to Physicians’ Prescription Habits
Jean-Christophe Bélisle-Pipon calls attention to issues of accessibility and transparency related to the collection and sale of physician prescribing data by data solution companies.
Clinical Trial Disaster in France
Jonathan Kimmelman comments on the recent phase 1 clinical research trial that left one healthy volunteer brain dead and five others hospitalized.
Margaret Lock Offers Dementia’s Realism Instead of Hope
Cynthia Martin writes that unlike cancer’s new push to accelerate treatment (recently launched under the banner Cancer Moonshot2020), there is no Alzheimer’s MoonShot2020.
Impact Ethics 